Look for PHE at ISPOR 2013

Examples of our expertise can be found in the following presentations:

Issue Panels – Session I

Monday, May 20th, 2013: 11:00am-12:00pm

“How Do We Balance Patient Value and Payer Cost in Oncology?”

Moderator: Dana Goldman, PHE Founding Partner

Workshops – Session III

Tuesday, May 2 ...

PHE Adds Anne L. Peters and Kari Edwards to Roster

PHE has added two leaders to supplement our unique business perspective: Anne Peters, MD, a nationally acclaimed expert in diabetes treatment in at-risk communities, will focus PHE’s research in this leading healthcare expenditure; Kari Edwards, PhD, will provide clients strategic counsel on t ...

Tomas Philipson Featured Panelist of Bio's "SuperSession"

Tomas Philipson appeared as a featured panelist of Bio International Convention's tentpole "SuperSession," held April 24th, 2013 in Chicago. The panel, addressing innovative alliances in Pharma, was moderated by CNN's Fareed Zakaria and featured Dr. Philipson, Dr. Trevor Mundel (President, Bill ...

Philipson Participates in Scientific American/TEDMED Panel Discussion

Scientific American, in partnership with TEDMED, hosted "The Value of Medical Innovation: A World Free From Cancer," in Washington, DC on April 16th, 2013.  Moderated by award-winning journalist and NPR host, David Brancaccio, this panel event helpd illustrate how sustained commitment to medical ...

Lakdawalla Quoted By Bloomberg on Novartis India Patent Ruling

Darius Lakdawalla was quoted by Bloomberg.com on the recent patent ruling handed down by India's Supreme Court to Novartis AG, regarding their cancer drug Glivec.  Read Dr. Lakdawalla's comments on innovation in the article here.

Bhattacharya, Jena, and Batt Added As PHE Principal Consultants

PHE has named Jay Bhattacharya, MD, PhD, Anupam Jena, MD, PhD, and Katherine Batt, MD, MSc, as principal consultants. All three are preeminent researchers and educators representing the most notable institutions in health economics and health policy; they will contribute to the knowledge base an ...

Obama Cites Philipson & Goldman in Economic Report of the President

Barack Obama's newly released "Economic Report of the President" cites Tomas Philipson's study of cancer treatment in the US vs. Europe, as it relates to the institution of the Affordable Care Act.  In addition, Dana Goldman's “U.S. Health Care:Facts About Costs, Access, and Quality” is al ...

Dr. Amitabh Chandra Named Chief Scientific Officer

PHE has named Dr. Amitabh Chandra as our new chief scientific officer, effective immediately.

Chandra is the director of health policy research, at Harvard’s Kennedy School of Government and professor of public policy at Harvard University; he will continue to serve in these roles. Internati ...

Philipson in Bloomberg.com: "FDA Reform Can Lift U.S. Economy"

PHE Partner Tomas Philipson, along with former FDA Commissioner Andrew von Eschenbach, offer an intriguing editorial to Bloomberg View, suggesting that the existing FDA approval process could be updated and improved, ultimately providing a significant bump the the overall US economy and GDP.  

PHE Welcomes New Chief Marketing Officer Mark A. Gianforcaro

PHE would like to welcome the newest member of our leadership team-- Mark A. Gianforcaro, RPh. Mark will serve as our chief marketing officer, supporting the expansion of the PHE brand and, ultimately, the overall growth of our business. “The persistent questions surrounding the cost and val ...

Wall Street Journal Opinion by PHE's Chandra, Jena, and Seabury: "Defensive Medicine"

A version of this article appeared February 8, 2013 in the U.S. edition of The Wall Street Journal:

Opinion: Defensive Medicine May Be Costlier Than It Seems

While economic studies don't show it, physicians say that fear of lawsuits spurs higher spending. They may be right.

By AMITABH CHANDRA, ...

Lakdawalla on AJMCtv: "Payer/Provider Relationship"

Darius Lakdawalla thinks that payers follow the lead of providers. The payers do what they think patients are demanding and are the "lagging indicators" in the system. "The more we can do to generate evidence to help physicians make clinically sound decisions and help to illustrate the value of ...

PHE Article Named To Health Affairs' Top Ten Most Read Articles of 2012

PHE founding partner Tomas Philipson's article, “An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case Of Cancer," written by Philipson, Michael Eber, Darius N. Lakdawalla, Dana P. Goldman, Mitra Corral, and Rena Conti has been n ...

Dana Goldman on National Journal Podcast: "Will Increased Competition in Health Care Exchanges Actually Raise Costs?"

Founding partner Dana Goldman was interviewed by The National Journal's Cory Bennett on the impact of the ACA's  planned health care exchanges-- and whether they will actually raise costs. Check out the complete podcast with the link below.

http://tinyurl.com/GoldmanNational-Journal

PHE Founding Partner Dana Goldman and RAND Co-Authors Find That the Mexican Immigrant Health Advantage Persist After Accounting for Undiagnosed Disease

The December Health Affairs issue features research by PHE Founding Partner Dana P. Goldman and RAND co-authors Slivia Helena Barcellos and James P. Smith. They find that undiagnosed disease partially explains the lower rates of diabetes and hypertension in the Mexican immigrant population, comp ...

Dana Goldman's NY Times Op-Ed: "Health Insurance Exchanges May Be Too Small to Succeed"

Founding PHE partner, along with PHE consultants and Harvard University faculty Anupam Jena and Michael Chernew, provide new insight in the NY Times Business Day Op-Ed: "Health Insurance Exchanges May Be Too Small to Succeed."  (Full Text runs below)

Multiple PHE Authors Featured in American Journal of Managed Care's Special Oncology Treatment Edition

The November 2012 special edition of The American Journal of Managed Care, focusing on new approaches to measuring value in oncology therapy, features four articles by key PHE co-authors. "Dynamic Cost-Effectiveness of Oncology Drugs" was co-authored by founding partner Tomas Philipson, "Value o ...

PHE Welcomes Glenn Bilawsky

PHE is pleased to announce the naming of Glenn Bilawsky as Chief Executive Officer.  You may know Glenn from his eight years of service as CEO of the i3 division of UnitedHealth Group. During his tenure, i3 grew five-fold and established itself as an admired brand recognized as the contract rese ...

PHE Founding Partner Dana Goldman in the New York Times: “Why Private Medicare Plans Don’t Cost Less”

Dana Goldman, along with Adam Leive and Nobel laureate Daniel McFadden, describes the government incentives which drive up the cost of Medicare Advantage above the cost of traditional Medicare. See below for an excerpt:

“Both insurers and consumers are making choices. Beneficiaries opt out o ...

Health Affairs Article on the Social Value of Statins

PHE co-authors Darius Lakdawalla, Dana Goldman, Michael Eber, Michael Chernew and Tomas Philipson calculate the social value of statins here, considering the value of long-term survival benefits in excess of spending on the therapy. They find that the social value of survival gains are large and ...

PHE Partners Lead Milken Institute's "Celebration of Science"

PHE Partners Dana Goldman, Darius Lakdawalla, and Tomas Philipson presented "The Economic Value of Medical Innovation" as part of The Milken Institute's "Celebration of Science," held in Washington, DC on September 7-9th, 2012. Focusing on the rapid advances s in biological research and medical ...

Dana Goldman Appears on MSNBC's Morning Joe: "Reimburse for Health"

Dana Goldman appeared on MSNBC's "Morning Joe" program to discuss the ACA, obesity, and the need for more emphasis on preventative care with co-hosts Joe Scarborough and Mika Brezezinski on Thursday, July 26th.  To see the complete interview, please click here.